A detailed history of Clear Creek Financial Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clear Creek Financial Management, LLC holds 4,737 shares of ABT stock, worth $543,618. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,737
Previous 4,663 1.59%
Holding current value
$543,618
Previous $484,000 11.57%
% of portfolio
0.06%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$100.07 - $118.13 $7,405 - $8,741
74 Added 1.59%
4,737 $540,000
Q2 2024

Jul 25, 2024

BUY
$100.73 - $112.44 $46,940 - $52,397
466 Added 11.1%
4,663 $484,000
Q1 2024

Apr 26, 2024

BUY
$109.52 - $120.96 $58,593 - $64,713
535 Added 14.61%
4,197 $477,000
Q4 2023

Jan 23, 2024

BUY
$90.19 - $110.4 $56,278 - $68,889
624 Added 20.54%
3,662 $403,000
Q3 2023

Oct 23, 2023

BUY
$95.53 - $114.62 $34,677 - $41,607
363 Added 13.57%
3,038 $294,000
Q2 2023

Jul 14, 2023

BUY
$100.78 - $112.29 $2,821 - $3,144
28 Added 1.06%
2,675 $291,000
Q1 2023

Apr 20, 2023

BUY
$96.86 - $114.01 $871 - $1,026
9 Added 0.34%
2,647 $268,000
Q4 2022

Jan 23, 2023

BUY
$95.06 - $111.52 $16,540 - $19,404
174 Added 7.06%
2,638 $0
Q3 2022

Oct 24, 2022

SELL
$96.76 - $112.03 $870 - $1,008
-9 Reduced 0.36%
2,464 $238,000
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $16,433 - $19,862
-161 Reduced 6.11%
2,473 $269,000
Q1 2022

May 02, 2022

BUY
$114.02 - $139.04 $3,648 - $4,449
32 Added 1.23%
2,634 $312,000
Q4 2021

Jan 21, 2022

SELL
$115.53 - $141.46 $7,162 - $8,770
-62 Reduced 2.33%
2,602 $366,000
Q3 2021

Oct 14, 2021

SELL
$116.66 - $129.06 $3,033 - $3,355
-26 Reduced 0.97%
2,664 $315,000
Q2 2021

Jul 30, 2021

BUY
$105.79 - $124.53 $95,316 - $112,201
901 Added 50.36%
2,690 $312,000
Q1 2021

Apr 23, 2021

SELL
$108.84 - $128.23 $120,812 - $142,335
-1,110 Reduced 38.29%
1,789 $220,000
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $304,395 - $331,703
2,899 New
2,899 $317,000
Q3 2020

Nov 10, 2020

SELL
$91.64 - $111.29 $269,055 - $326,747
-2,936 Closed
0 $0
Q2 2020

Jul 16, 2020

SELL
$76.57 - $98.0 $227,795 - $291,550
-2,975 Reduced 50.33%
2,936 $268,000
Q1 2020

Apr 23, 2020

BUY
$62.82 - $91.86 $203,662 - $297,810
3,242 Added 121.47%
5,911 $572,000
Q4 2019

Jan 17, 2020

SELL
$78.51 - $87.4 $1,570 - $1,748
-20 Reduced 0.74%
2,669 $230,000
Q3 2019

Nov 15, 2019

SELL
$81.84 - $88.74 $14,240 - $15,440
-174 Reduced 6.08%
2,689 $227,000
Q2 2019

Aug 16, 2019

BUY
$72.88 - $85.0 $208,655 - $243,355
2,863 New
2,863 $240,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clear Creek Financial Management, LLC Portfolio

Follow Clear Creek Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Creek Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Creek Financial Management, LLC with notifications on news.